New Key Statistics Module, Z-Score and F-Score
NAS:AMLX Key Ratios
Market Cap $ M | 140.43 |
Enterprise Value $ M | -231.11 |
P/E(ttm) | 2.95 |
PE Ratio without NRI | 2.95 |
Forward PE Ratio | -- |
Price/Book | 0.32 |
Price/Sales | 0.37 |
Price/Free Cash Flow | 12.66 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 380.00 |
EPS (TTM) $ | 0.70 |
Beneish M-Score | 23 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -5.96 |
EV-to-EBITDA | -5.79 |
PEG | -- |
Shares Outstanding M | 68.01 |
Net Margin (%) | 12.94 |
Operating Margin % | 10.19 |
Pre-tax Margin (%) | 14.26 |
Quick Ratio | 5.20 |
Current Ratio | 5.66 |
ROA % (ttm) | 11.01 |
ROE % (ttm) | 12.75 |
ROIC % (ttm) | 68.06 |
Dividend Yield % | -- |
Altman Z-Score | 2.08 |
AMLX Number of Guru Trades
AMLX Volume of Guru Trades
Gurus Latest Trades with NAS:AMLX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:AMLX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Amylyx Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:AMLX
Total 0- 1